Clinical Trial Update: Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of SAR 1118 for dry eye disease and keratoconjunctivitis sicca completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Keratoconjunctivitis Sicca

Drugs mentioned

• SAR 1118

Snippet

Sponsor: Shire | Conditions: Keratoconjunctivitis Sicca, Dry Eye Disease | Phase 3 | Status: COMPLETED | Results posted: 2017-02-24